Alpha Teknova
TKNO | NASDAQ
$7.77
-$0.44 (-5.36%)
At close: Nov 16, 2026, 4:00 PM ET
$7.77
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Alpha Teknova Company Profile
Company profile explainedCompany Profile
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Key Executives
| Name | Position |
|---|---|
| Stephen Gunstream | President, Chief Executive Officer & Director |
| Matthew C. Lowell | Chief Financial Officer |
| Damon A. Terrill | General Counsel, Chief Compliance Officer & Secretary |
| Jennifer Henry | Senior Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 21, 2026 | 8-K | Current Report |
| Oct 21, 2026 | 424B5 | Filing |
| Oct 20, 2026 | 424B5 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Jul 16, 2026 | 4 | Filing |
| Jun 02, 2026 | 4 | Filing |
| Jun 02, 2026 | 4 | Filing |
| Jun 02, 2026 | 4 | Filing |
| Jun 01, 2026 | 8-K | Current Report |
Alpha Teknova
| Country | United States |
| IPO Date | Jun 25, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 158 |
| CEO | Stephen Gunstream |
Contact Details
2290 Bert Drive Hollister,
California 95023 United States
Stock Details
| Ticker Symbol | TKNO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001850902 |
| CUSIP Number | 02080L102 |
| ISIN Number | US02080L1026 |
| SIC Code | 2835 |
Add to Watchlist
Select watchlists to add or remove TKNO